Ontology highlight
ABSTRACT:
SUBMITTER: Kocher M
PROVIDER: S-EPMC8156090 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
Kocher Martin M Jockwitz Christiane C Lohmann Philipp P Stoffels Gabriele G Filss Christian C Mottaghy Felix M FM Ruge Maximilian I MI Weiss Lucas Carolin C Goldbrunner Roland R Shah Nadim J NJ Fink Gereon R GR Galldiks Norbert N Langen Karl-Josef KJ Caspers Svenja S
Cancers 20210514 10
Cognitive deficits are common in glioma patients following multimodality therapy, but the relative impact of different types and locations of treatment-related brain damage and recurrent tumors on cognition is not well understood. In 121 WHO Grade III/IV glioma patients, structural MRI, <i>O</i>-(2-[18F]fluoroethyl)-L-tyrosine FET-PET, and neuropsychological testing were performed at a median interval of 14 months (range, 1-214 months) after therapy initiation. Resection cavities, T1-enhancing l ...[more]